Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis-Reference-Cited by-同舟云学术

Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis

Published:2010-02-26 Issue:6 Volume:62 Page:1792-1802
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Ruperto Nicolino,Lovell Daniel J.,Quartier Pierre,Paz Eliana,Rubio-Pérez Nadina,Silva Clovis A.,Abud-Mendoza Carlos,Burgos-Vargas Ruben,Gerloni Valeria,Melo-Gomes Jose A.,Saad-Magalhães Claudia,Chavez-Corrales J.,Huemer Christian,Kivitz Alan,Blanco Francisco J.,Foeldvari Ivan,Hofer Michael,Horneff Gerd,Huppertz Hans-Iko,Job-Deslandre Chantal,Loy Anna,Minden Kirsten,Punaro Marilynn,Nunez Alejandro Flores,Sigal Leonard H.,Block Alan J.,Nys Marleen,Martini Alberto,Giannini Edward H.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.27431/fullpdf

Reference35 articles.

1. Juvenile idiopathic arthritis;Ravelli;Lancet,2007

2. Prevalence of and annual ambulatory health care visits for pediatric arthritis and other rheumatologic conditions in the United States in 2001-2004;Sacks;Arthritis Rheum,2007

3. Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality of life cohort study;Oliveira;Arthritis Rheum,2007

4. Quality of life and impact of the disease on primary caregivers of juvenile idiopathic arthritis patients;Bruns;Joint Bone Spine,2008

5. Assessing current outcomes of juvenile idiopathic arthritis: a cross-sectional study in a tertiary center sample;Solari;Arthritis Rheum,2008

Cited by 201 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study;Annals of the Rheumatic Diseases;2024-06-07

2. Polyarticular juvenile idiopathic arthritis has a distinct co-inhibitor receptor profile;Rheumatology;2024-05-23

3. Antibodies targeting the shared cytokine receptor IL-1 receptor accessory protein invoke distinct mechanisms to block all cytokine signaling;Cell Reports;2024-05

4. Drug therapy in juvenile spondyloarthritis;Current Opinion in Rheumatology;2024-04-22

5. Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registry;Rheumatology;2024-01-18